Anticancer potentiated bioactive compounds from marine flora

Cancer is responsible for around one of every six deaths around the world. It is the driving reason for death internationally, with 8.7 million deaths in 2015. Factors that increase the risk of cancer include tobacco use (22% of cancer death), alcohol consuming, poor nutrients diet, a sedentary lifestyle of the human. These elements are believed to account for roughly 33% of cancer deaths. The most common malignancies in women are breast, cervical, lung, thyroid, and colorectal cancers, whereas prostate, lung, colorectal, liver, and stomach cancers are the most common cancers in men. Although several techniques are used in treating cancer, including radiation treatment, medical procedures, immunotherapy, and endocrine treatment, chemotherapy is the most widely recognized form of cancer therapy. Recent research shows that more than 90% of cancer deaths can be ascribed to drug resistance. There are a variety of methods for treating cancer patients with advanced stages, such as inhibiting drug efflux protein, suppressing DNA repair factors, and down-regulated abnormal xenobiotic metabolism. However, clinical utilization of synthetic drugs is associated with undesirable impacts such as suppression of bone marrow, gastrointestinal ulcers, neurological disorders, and cardiac toxicity. Cancer-related death rates are observed to remain high, with little attention given to substantial research and investigation efforts with medically innovative clinical underpinnings that make use of new pharmacological agents.